tiprankstipranks
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
US Market
TAK
Takeda Pharmaceutical Company
RESEARCH TOOLSreports

Takeda Pharmaceutical Company (TAK) Stock News & Sentiment

1,347 Followers
Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push
Premium
Company Announcements
Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push
1d ago
TAK
Takeda’s Long-Term Psoriatic Arthritis Trial Could Reshape TAK’s Immunology Outlook
Premium
Company Announcements
Takeda’s Long-Term Psoriatic Arthritis Trial Could Reshape TAK’s Immunology Outlook
23d ago
TAK
Takeda Advances Dual-Therapy Ulcerative Colitis Study, Keeping Entyvio in the GI Spotlight
Premium
Company Announcements
Takeda Advances Dual-Therapy Ulcerative Colitis Study, Keeping Entyvio in the GI Spotlight
24d ago
TAK
Takeda’s Dual-Drug Crohn’s Study Could Reframe Entyvio’s Role in IBD Portfolios
Premium
Company Announcements
Takeda’s Dual-Drug Crohn’s Study Could Reframe Entyvio’s Role in IBD Portfolios
24d ago
TAK
Takeda Tracks Real-World Safety of Alunbrig in Japanese Lung Cancer Patients
Premium
Company Announcements
Takeda Tracks Real-World Safety of Alunbrig in Japanese Lung Cancer Patients
25d ago
TAK
Takeda’s New South Korea HAE Study Aims to Cement Takhzyro’s Real World Edge
Premium
Company Announcements
Takeda’s New South Korea HAE Study Aims to Cement Takhzyro’s Real World Edge
29d ago
TAK
Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside
Premium
Company Announcements
Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside
29d ago
TAK
More TAK News >

TAK News on the Web

Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push
TipRanks News
Neutral
Is ADMA Poised for Margin Growth and Supply Expansion in 2026?
Zacks
Neutral
Takeda upgraded to Outperform from Market Perform at Bernstein
TipRanks News
Bullish
Denali Stock Falls as Partner Takeda Ends Collaboration Deal
Zacks
Bearish
Denali Therapeutics regains full rights to DNL593
TipRanks News
Bearish
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
rttnews
Neutral
Abivax appoints Michael Nesrallah as chief commercial officer
TipRanks News
Neutral
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?
Zacks
Neutral

News Score - Last 7 Days

Negative
TAK
Sector Average
Media Buzz
This Week5 articles
Weekly Average5.5 articles
News Sentiment
This Week33%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TAK’s Media Buzz Sentiment?
5 articles about TAK were published this week. In an average week, 5.5 articles are published.
    What is TAK’s weekly average amount of articles?
    In an average week, 5.5 articles about TAK are published.
      What is TAK’s News Sentiment?
      33% of articles about TAK were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week